The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis.

导出 OA

翻译打印收藏纠错

第一作者： Eric J,Allenspach

第一单位： Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; drawling@uw.edu ealle2@uw.edu.

作者： Eric J,Allenspach ^[1] ; Nicholas J,Shubin ^[2] ; Karen,Cerosaletti ^[3] ; Carmen,Mikacenic ^[4] ; Jacquelyn A,Gorman ^[4] ; Matthew A,MacQuivey ^[5] ; Aaron B I,Rosen ^[3] ; Andrew E,Timms ^[3] ; Michelle N,Wray-Dutra ^[3] ; Kerri,Niino ^[3] ; Denny,Liggitt ^[3] ; Mark M,Wurfel ^[3] ; Jane H,Buckner ^[6] ; Adrian M,Piliponsky ^[5] ; David J,Rawlings ^[4]

作者单位： Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; drawling@uw.edu ealle2@uw.edu. ^[1] Department of Pediatrics, University of Washington, Seattle, WA. ^[2] Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA. ^[3] Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA. ^[4] Department of Medicine, Division of Pulmonary and Critical Care, University of Washington, Seattle, WA. ^[5] Department of Comparative Medicine, University of Washington, Seattle, WA. ^[6] Department of Immunology, University of Washington, Seattle, WA. ^[7] Department of Pediatrics, University of Washington School of Medicine, Seattle, WA. ^[8] Department of Pathology, University of Washington School of Medicine, Seattle, WA; and. ^[9] Department of Global Health, University of Washington School of Medicine, Seattle, WA. ^[10]